Are these medications safe for long-term use
How to Inject BPC-157 Safely Under Medical Guidance Subcutaneous Injections: Simple and Effective Best for: Systemic healing or mild injuries Location: Abdomen or near the injured area Needle: 2931 gauge, inch Technique Clean vial top and skin with an alcohol pad Draw reconstituted peptide with a sterile syringe Pinch skin and inject at a 4590 angle Dispose of the needle properly Intramuscular Injections: Deeper Targeting Best for: Deep tissue, ligament, or tendon repair Needle: 2730 gauge, 1 inch Inject near injury site for maximum effect Rotate injection sites to prevent irritation Stacking BPC-157 With Other Peptides BPC-157 + TB-500 Goal: Accelerate healing and flexibility Protocol: BPC-157 250500 mcg daily (local injection) TB-500 25 mg weekly (divided doses) These two peptides complement each other: BPC-157 targets the injured tissue, while TB-500 promotes systemic healing
Decreased hepatic glutathione levels in septic shock: predisposition of hepatocytes to oxidative stress: an experimental approach
The article states that both semaglutide and tirzepatide carry black box warnings for thyroid C-cell tumors observed in animal studies, and that both are contraindicated in people with a personal or family history of medullary thyroid cancer or MEN 2 syndrome
Another point of discussion is the existence of different forms of melanomas as outlined by Lipsker: Thin melanomas, slowgrowing, with a strong increase in incidence across time and associated with intermittent sun exposure, typical in persons with large number of nevi, and positive BRAF mutations
This is important information
